Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(100.0%)
5Total
N/A(5)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT04358146Not ApplicableRecruiting

Study on the Efficacy and Tolerance of a New Anti-regurgitation Infant Formula (STELLAR)

Role: collaborator

NCT05978180Not ApplicableCompleted

Safety of Use and Efficacy of Pandora for Patients Suffering From Gonarthrosis (PANDORA2)

Role: collaborator

NCT05414617Not ApplicableCompleted

Safety of Use of Pandora for Patients Suffering From Gonarthrosis

Role: collaborator

NCT02657265Not ApplicableCompleted

SpineJack® Versus Conservative Treatment Study (SPICO Study)

Role: collaborator

NCT03557671Not ApplicableCompleted

Evaluation of the Hypoallergenicity of a New Formula Based on Hydrolyzed Rice Proteins

Role: collaborator

All 5 trials loaded